Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:PEBO
NasdaqGS:PEBOBanks

Peoples Bancorp (PEBO) Valuation Check After Earnings Growth And Margin Expansion

Peoples Bancorp (PEBO) has drawn fresh attention after reporting fourth quarter 2025 results, including higher net interest income, an 86.4% rise in net earnings, and an affirmed quarterly cash dividend of $0.41 per share. See our latest analysis for Peoples Bancorp. The recent earnings beat and dividend affirmation have come alongside a 90 day share price return of 12.76% and a 1 year total shareholder return of 5.25%. The 3 year total shareholder return of 25.08% points to steadier gains...
NYSE:AFL
NYSE:AFLInsurance

Is Aflac (AFL) Attractively Priced After Strong Multi Year Share Price Performance

If you are wondering whether Aflac's current share price reflects its real worth, you are not alone. This article focuses squarely on what you are getting for the price you pay. Aflac last closed at US$110.95, with returns of 3.6% over the past 7 days, 0.6% over 30 days, 0.6% year to date, 5.6% over 1 year, 70.8% over 3 years and 174.2% over 5 years. Recent attention on Aflac has been shaped by ongoing coverage of its role in the insurance sector and discussion around how its long term share...
ASX:DDR
ASX:DDRElectronic

ASX Dividend Stocks To Consider In February 2026

As the Australian market shows signs of recovery from recent volatility, with the ASX 200 futures indicating a positive start to the trading day, investors are keeping a close eye on upcoming economic events such as the RBA meeting. In this environment, dividend stocks can be an attractive choice for those seeking steady income and potential resilience amidst fluctuating market conditions.
ASX:C79
ASX:C79Professional Services

3 ASX Growth Stocks With Insider Ownership Growing Earnings Up To 65%

As the Australian market shows signs of resilience following a recent sell-off, investors are keeping a close eye on potential opportunities amid a generally positive outlook. In such an environment, growth companies with high insider ownership can be particularly appealing, as they often indicate strong confidence from those who know the business best and may offer promising earnings potential.
ASX:LNW
ASX:LNWHospitality

3 ASX Stocks Estimated To Be 13.2% To 25.1% Below Their Intrinsic Value

As the Australian market shows signs of resilience, with the ASX 200 futures indicating a potential recovery from recent sell-offs, investors are keenly observing opportunities that may arise amidst global economic uncertainties. In such a climate, identifying undervalued stocks can be particularly appealing, as these assets offer potential for growth when trading below their intrinsic value.
ASX:FHE
ASX:FHERenewable Energy

3 ASX Penny Stocks With Market Caps Under A$600M To Consider

As the Australian market shows signs of recovery, with the ASX 200 futures indicating a potential uptick, investors are keeping a close eye on various opportunities. Penny stocks, often associated with smaller or newer companies, remain an intriguing area for those looking to diversify their portfolios beyond well-known names. Despite being considered somewhat outdated as a term, penny stocks continue to offer potential growth opportunities when backed by strong financial health.
NYSE:BEN
NYSE:BENCapital Markets

Franklin Resources Q1 Net Inflows Challenge Bearish Narratives On AUM Pressure

Franklin Resources (BEN) opened fiscal 2026 with Q1 revenue of US$2.3 billion and basic EPS of US$0.49, alongside net income of US$255.5 million and trailing twelve month EPS of US$1.09. This sets a clear marker for how the year is starting to shape up. Over recent periods, revenue has moved from US$2.2 billion in Q4 2024 to US$2.1 billion in Q2 2025, US$2.1 billion in Q3 2025, US$2.3 billion in Q4 2025 and now US$2.3 billion in Q1 2026, while quarterly EPS has ranged from a loss of US$0.18...
NasdaqGS:SONO
NasdaqGS:SONOConsumer Durables

Is Sonos (SONO) Pricing Too Rich After Mixed Long Term Share Performance

If you are looking at Sonos and wondering whether the current share price gives you good value, you are not alone. This article will walk through what that price really reflects. Sonos shares last closed at US$14.35, with returns of a 3.8% decline over 7 days, an 18.0% decline over 30 days, an 18.0% decline year to date, a 4.1% gain over 1 year, a 24.1% decline over 3 years, and a 53.7% decline over 5 years. These mixed returns have put a spotlight on what might be driving the share price,...
NZSE:AIA
NZSE:AIAInfrastructure

Should Auckland Airport’s (NZSE:AIA) New Board Appointment and Traffic Data Disclosure Require Action From Investors?

Auckland International Airport has appointed former Dallas Fort Worth International Airport chief executive Sean Donohue to its board, effective January 30, 2026, while also reporting detailed passenger and aircraft movement statistics for Auckland and Queenstown airports to December 2025. Donohue’s track record in major infrastructure delivery, digital upgrades and carbon net zero initiatives introduces fresh aviation expertise to Auckland Airport’s governance just as its traffic volumes...
NYSE:MTX
NYSE:MTXChemicals

Minerals Technologies Balances Record Safety, Growth Investments And Talc Litigation Costs

Minerals Technologies reported a record company safety performance in 2025, setting a new benchmark for its operations. The company increased investment in growth platforms across pet litter, edible oil purification, and paper and packaging in key global markets. Engineered Solutions delivered record profitability in a challenging market, while Minerals Technologies continued to incur talc related litigation costs. For investors tracking NYSE:MTX, the recent news adds important context to a...
SEHK:656
SEHK:656Industrials

Is Fosun International (SEHK:656) Offering Value After Prolonged Share Price Declines

If you are wondering whether Fosun International's share price reflects its underlying value, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at HK$4.16, with returns of 0.2% over 7 days, a 5.0% decline over 30 days, a 5.2% decline year to date, and a 1.7% decline over 1 year. The 3 year and 5 year returns show declines of 43.4% and 61.6% respectively. These price moves have put valuation back on many investors' radar, especially as...
NasdaqGS:ASML
NasdaqGS:ASMLSemiconductor

Intel Move Puts ASML High NA EUV At Center Of Chip Race

Intel has begun adopting ASML Holding's next generation high-NA EUV lithography systems as part of its latest manufacturing roadmap. The first commercial high-NA EUV system from ASML has now been installed at Intel, marking a key step in advanced chip production. Intel aims to use this equipment in its effort to regain market share in cutting edge manufacturing from TSMC. ASML Holding (NasdaqGS:ASML) sits at the center of this shift, supplying the high-NA EUV tools that enable smaller, more...
CPSE:AMBU B
CPSE:AMBU BMedical Equipment

Ambu’s China-Focused Supply Shift Could Be A Game Changer For Ambu (CPSE:AMBU B)

Recently, Ambu’s CEO Britt Meelby Jensen joined a Danish life science delegation to China, presenting a new Chinese-made endoscope as part of efforts to deepen cooperation and diversify the company’s global value chain away from a more difficult US market. This move highlights how Ambu is reconfiguring its manufacturing and market exposure to tap Chinese healthcare demand while reducing reliance on a single geography. We’ll now examine how Ambu’s increased focus on Chinese manufacturing and...
TSE:8766
TSE:8766Insurance

Is It Too Late To Consider Tokio Marine Holdings (TSE:8766) After Its Strong Multi‑Year Run?

If you are wondering whether Tokio Marine Holdings is still reasonably priced after a strong run, you are not alone; many investors are asking the same question. The share price is currently ¥5,727, with returns of 14.6% over 1 year, very large growth over 5 years, and shorter term moves of a 2.3% decline over 7 days and a 1.5% decline over 30 days, plus a 3.1% decline year to date. Recent coverage of Tokio Marine has focused on its position in the Japanese insurance sector and how investors...
NYSE:ATHM
NYSE:ATHMInteractive Media and Services

Should Autohome’s (ATHM) Special Dividend and Rising Institutional Stakes Prompt a Portfolio Review?

Autohome recently announced a special dividend to be paid on February 19th to shareholders of record as of December 31st, while institutional investors such as Federated Hermes, Invesco and Schroder Investment Management Group increased their holdings in the company during the third quarter. The combination of a one-off cash return to shareholders and growing institutional participation highlights how capital allocation and investor mix are evolving for Autohome. Next, we will examine how...
NYSE:LTH
NYSE:LTHHospitality

How Investors Are Reacting To Life Time Group Holdings (LTH) Guiding Higher 2026 Sales But Lower Profit

In January 2026, Life Time Group Holdings issued earnings guidance, projecting fourth-quarter 2025 revenue of US$743 million–US$745 million and net income of US$120 million–US$123 million, alongside full-year 2025 and 2026 outlooks. An interesting aspect of the update is that while 2026 revenue is guided higher at about US$3.30 billion–US$3.33 billion, the company anticipates lower net income of US$330 million–US$336 million compared with its 2025 forecast. Next, we will examine how Life...
SWX:ROG
SWX:ROGPharmaceuticals

Roche Holding (SWX:ROG) Net Margin Jump To 20.3% Tests Long Term EPS Bear Case

How Roche Holding (SWX:ROG) Just Framed Its FY 2025 Story Roche Holding (SWX:ROG) opened FY 2025 with first half revenue of CHF31.8b and basic EPS of CHF9.31, setting the tone with headline numbers that put both the top line and per share earnings clearly on the radar for investors following this latest update. Over the recent reporting periods, revenue has moved from CHF30.8b in the first half of 2024 to CHF31.6b in the second half and then to CHF31.8b in the first half of 2025. Basic EPS...
OM:BILL
OM:BILLPackaging

Billerud (OM:BILL) Margin Compression To 1.8% Tests Bullish Growth Narrative

Billerud (OM:BILL) has wrapped up FY 2025 with fourth quarter revenue of SEK 9.1b and basic EPS of SEK 1.22, setting the tone for a year that swung from loss to profit at the quarterly level. Over recent periods, the company has seen quarterly revenue move from SEK 11.6b and EPS of SEK 3.24 in Q4 2024 to SEK 11.1b and EPS of SEK 1.67 in Q1 2025, SEK 10.4b and EPS of SEK 0.22 in Q2, and SEK 9.9b and an EPS loss of SEK 0.25 in Q3, before landing at the latest Q4 result. This leaves margins...
NasdaqGS:ENTG
NasdaqGS:ENTGSemiconductor

Entegris CFO Change Puts Valuation And Debt Coverage In Focus

Entegris (NasdaqGS:ENTG) has announced a CFO transition, with Linda LaGorga stepping down from the role. Mike Sauer, an experienced internal executive, has been appointed Interim CFO. The change represents a material shift in the finance leadership team that investors may want to watch closely. For shareholders, this executive turnover comes at a time when Entegris shares trade around $118.07. The stock has recent momentum, with a 2.9% return over the past week, 31.8% over the past month,...
NYSE:WHD
NYSE:WHDEnergy Services

Is Rising Institutional Ownership Quietly Redefining Cactus (WHD)’s Role in Energy Portfolios?

Over the past six months, Cactus, Inc. has drawn increased interest from large institutional investors, reflecting confidence in its recent three-year sales and earnings per share growth record. This combination of robust historical fundamentals and growing institutional ownership has strengthened Cactus’s role as a potential core holding within diversified energy-focused portfolios. Next, we will examine how rising institutional demand, underpinned by Cactus’s multi‑year earnings expansion,...
NasdaqGS:IPAR
NasdaqGS:IPARPersonal Products

Assessing Interparfums (IPAR) Valuation After New David Beckham And Nautica Licensing Deals

Interparfums (IPAR) has expanded its fragrance portfolio with long term global licensing deals for David Beckham and Nautica, agreements that introduce established brands and projected sales figures into its future revenue mix. See our latest analysis for Interparfums. The recent licensing announcements arrive after a mixed share price pattern, with a 14.2% 1 month share price return and a 7.7% 3 month share price return, but a 1 year total shareholder return decline of 28.8%. This suggests...
BIT:MB
BIT:MBBanks

Evaluating Mediobanca (BIT:MB) After Solid Full Year Results And Net Profit Growth

What Mediobanca’s latest results mean for shareholders Mediobanca Banca di Credito Finanziario (BIT:MB) recently reported a solid full-year performance, with net profit growing year on year, an outcome that has helped reset market expectations around the bank’s shares. This earnings backdrop arrives after a period of share price swings. It gives you fresh financial data to weigh against recent returns, valuation signals, and the bank’s broader business mix across wealth management, consumer...
ENXTLS:EDP
ENXTLS:EDPElectric Utilities

What EDP (ENXTLS:EDP)'s New 150 MW Indiana Solar Project Means For Shareholders

EDP Renewables North America has begun commercial operations at its 150‑MW Riverstart Solar IV project in Randolph County, Indiana, which is now supplying clean power to tens of thousands of homes and businesses. This launch lifts EDPR NA’s operating capacity in Indiana to 2 GW, reinforcing its role as the state’s largest clean energy operator. We’ll now examine how the Riverstart Solar IV expansion, and the company’s growing 2 GW Indiana footprint, shape EDP’s investment narrative. Rare...
ENXTBR:ARGX
ENXTBR:ARGXBiotechs

How FDA Priority Review For VYVGART’s Seronegative gMG Use At argenx (ENXTBR:ARGX) Has Changed Its Investment Story

In January, argenx reported continued momentum for its autoimmune drug VYVGART, as the US FDA accepted a priority review of a supplemental biologics license application to extend its use to adults with acetylcholine receptor antibody‑seronegative generalized myasthenia gravis, while the franchise continued to post strong global sales growth in 2025. This combination of regulatory progress and broader clinical ambitions, spanning indications like immune thrombocytopenia, myositis and...